Clinical Trials Browser

Amyloidosis, Hereditary, Transthyretin-Related, Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease, Amyloidosis, Amyloid Neuropathies, Familial

Clinical Trials

MED-hATTR

Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study

A Study of Ninlaro in Real World Clinical Practice in China

Biomarkers of AKI in Patients Receiving Daratumumab

Genome Expression in Lymphoma, Leukemia and Multiple Myeloma

Evaluation of Comprehensive Geriatric Assessment and Laboratory Biomarkers in Elderly Patients With Multiple Myeloma

NIRVANA

iPREFER

Covid-19 Vaccine Responsiveness in MM and Waldenstrom

A Study of the Bortezomib, Lenalidomide, and Dexamethasone Regimen for the Treatment of Newly Diagnosed Multiple Myeloma Patients

Multiple Myeloma Prognostic Indices

Financial Difficulty in Patients With Blood Cancer

Establishment of a Strategy for Preventing Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation by Exploring Immune Mechanisms of Regulatory and Effector T Cells

Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events

Perspectives of Subcutaneous Velcade at Home of Patients With Myeloma.

LOOMIS

DILEMMA

A Study to Evaluate the Safety of Empliciti® (Elotuzumab) When Treating Patients With Multiple Myeloma in Taiwan

A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US

KEEPER

A Comparative Clinical Study to Determine the Optimal Initial Therapy for Multiple Myeloma

A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma as Compared With Standard of Care Therapies

Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma

Pomalyst PMS

LocoMMotion

Treatment of Relapsed/Refractory Multiple Myeloma (rrMM) With Pomalidomide in Clinical Practice

FKTMM2022

Real-World Analysis of Belantamab Mafodotin Care Patterns in Patients With Relapsed and/or Refractory Multiple Myeloma

Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple Myeloma

Immune Profiling in Multiple Myeloma

Patient With MMRR Treated With Belantamab Mafotidine on Monotherapy

Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey

Genomic and Phenotypic Determinants of Resistance to Immunotherapies in Multiple Myeloma

Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression

A Multicenter Cross-sectional Study on Mental Health of Patients With Multiple Myeloma

A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma

Screening to Improve Survival in AL Amyloidosis

Study of the Immune Response After Vaccination in Multiple Myeloma Patients

MYLENE

QoL-MM

Incidence of Hyperpigmentation in Black Patients With Multiple Myeloma Treated With Immunomodulatory Drugs

OMYFIN

A Study of Real-World Use of Ixazomib Citrate in People With Multiple Myeloma (MM)

DOrianT

A Survey on NINLARO Risk Management Plan (RMP) Material Utilization Among Pharmacists in Japan

A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma

BISPEMM

Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide

MICRO-MM

Detection of Poor Mobilizer (PM) in Multiple Myeloma (MM) Patients